DKSH
DKSH is a Swiss-listed market expansion services provider operating across 35 markets with 26,840 specialists, offering distribution, regulatory, sales, and marketing services to multinational pharmaceutical, consumer goods, and technology brands seeking Asia Pacific market access.
- Company typePublic
- Founded1869
- HeadquartersZürich, Switzerland
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What DKSH does
DKSH Holding Ltd. is a publicly-listed Swiss market expansion services provider (SIX:DKSH) operating across 35 markets in Asia Pacific, Europe, and North America with 26,840 specialists. The company provides end-to-end commercialization services — including sourcing, regulatory affairs, distribution, logistics, sales, marketing, and after-sales support — to multinational brand owners seeking market access without building their own local infrastructure.
The business is organized into four operating units: Healthcare (CHF 5.8B in 2025 net sales, the #1 pharma and OTC distributor in Asia across 17 markets), Consumer Goods (CHF 3.376B), Performance Materials (CHF 1.36B), and Technology (CHF 513.5M). Underlying technology platforms include the AI-integrated ConnectPlus by Euris CRM, Salesforce-based regional marketing platforms, AI-powered retail execution tools, and the Lab Solutions digital portal. Revenue is generated primarily through distribution margins and transaction fees on commercialized product volume rather than licensing or SaaS models.
DKSH generated FY2025 net sales of CHF 11.1B, Core EBIT of CHF 349M (3.2% margin, 5th consecutive year of expansion), and free cash flow of CHF 215.5M at a 95.2% conversion rate. The strategy combines organic growth with an active M&A program (9 transactions in 2025) targeting bolt-on acquisitions in ingredient distribution, specialty healthcare, and lab services, while divesting non-core assets such as the Australia/Taiwan cables businesses. The Keller family maintains anchor shareholder status via Diethelm Keller Holding, with leadership transition to Julie von Wedel-Keller as 5th-generation family representative on the board.
DKSH firmographics
Firmographics- Name
- DKSH
- Legal name
- DKSH Holding Ltd.
- Website
- https://dksh.com
- Company type
- Public
- Founded year
- 1869
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- DKSH is a Swiss-listed market expansion services provider operating across 35 markets with 26,840 specialists, offering distribution, regulatory, sales, and marketing services to multinational pharmaceutical, consumer goods, and technology brands seeking Asia Pacific market access.
- Ownership category
- akta.pro rank
DKSH industry classification
Industry- Product category
- Market Expansion Services
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)
- akta.pro secondary industries
- Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG), Durable Medical Equipment (DME) & Home Health Distribution (CRAOAHAF)
Keywords
Where DKSH is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices7 records
Markets served
DKSH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Distribution and Commercialization Services: DKSH generates revenue by providing comprehensive market expansion services including distribution, marketing, sales, logistics, and regulatory support for consumer goods, healthcare, performance materials, and technology products. Revenue is generated through service fees, distribution margins, and commercialization agreements with brand owners.
- Healthcare Distribution: Healthcare business unit generates CHF 5.8 billion in net sales through pharmaceutical distribution, consumer health products, and medical device distribution across 17 Asia Pacific markets and Switzerland.
- Consumer Goods Distribution: Consumer goods business unit generates CHF 3.4 billion through distribution of FMCG, luxury goods, beauty products, and food service products across Asia Pacific markets.
- Performance Materials Distribution: Performance materials business unit generates CHF 1.4 billion through distribution of specialty chemicals, food ingredients, and pharmaceutical ingredients.
- Technology Distribution: Technology business unit generates CHF 513.5 million through distribution of scientific instruments, precision machinery, and analytical equipment across 16 markets.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
DKSH product offering
Product offeringCore offering
DKSH provides end-to-end Market Expansion Services across Asia Pacific, Europe, and North America, enabling multinational brand owners to enter and grow in regional markets without building their own infrastructure. Its services span sourcing, market insights, regulatory affairs, marketing, sales, distribution, logistics, warehousing, and after-sales support across four business units: Healthcare (pharma, consumer health, OTC, medical devices), Consumer Goods (FMCG, luxury, beauty, food service), Performance Materials (specialty chemicals and ingredients), and Technology (scientific instruments, precision machinery, semiconductor equipment).
Product overview
DKSH is a Market Expansion Services provider operating four business units (Healthcare, Consumer Goods, Performance Materials, and Technology) that collectively offer a comprehensive portfolio of distribution, logistics, marketing, sales, regulatory, and after-sales services. The Healthcare Business Unit (CHF 5.8 billion net sales in 2025) focuses on pharmaceuticals, consumer health, and medical devices across 17 Asia Pacific markets; Consumer Goods serves fast-moving consumer goods, food service, luxury brands, and beauty products; Performance Materials handles specialty ingredients for food, personal care, and chemicals; and Technology distributes scientific instruments, precision machinery, and semiconductor equipment. Key platforms include ConnectPlus by Euris (AI-powered CRM for healthcare engagement) and Lab Solutions by DKSH (scientific expertise portal). The company connects multinational brands with Asian markets through end-to-end commercialization capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- DKSH Consumer Goods: Business unit focused on fast moving consumer goods, food services, luxury & lifestyle, beauty & wellness
- DKSH Healthcare
- DKSH Performance Materials
- DKSH Technology
- DKSH Premium Brands
- ConnectPlus by Euris
- Patient Solutions
- Lab Solutions by DKSH
Products and services
- DKSH Healthcare Business Unit End-to-end commercialization and market expansion services for pharmaceutical, consumer health, OTC, and medical device products across 17 Asia Pacific markets and Switzerland. Service scope includes distribution, regulatory affairs, commercial outsourcing, patient solutions, and after-sales support. Generates CHF 5.8 billion in net sales (2025) and is recognized as the #1 distributor in Asia for pharma and OTC.
- DKSH Consumer Goods Business Unit Market expansion services for fast-moving consumer goods, food service, luxury and lifestyle, and beauty and wellness brands across Asia Pacific, including marketing, sales, distribution, and eCommerce enablement. Generates CHF 3.376 billion in net sales (2025).
- DKSH Performance Materials Business Unit Distribution and market expansion services for food and beverage ingredients, personal care ingredients, pharmaceutical ingredients, and specialty chemicals across Asia Pacific and Europe. Includes formulation support, regulatory compliance, and logistics. Generates CHF 1.36 billion in net sales (2025).
- DKSH Technology Business Unit Distribution of scientific instruments, precision machinery, commercial and industrial equipment, and semiconductor and electronics products across 16 Asia Pacific markets. Includes sales, marketing, application engineering, installation, calibration, and after-sales service through 19 showrooms. Generates CHF 513.5 million in net sales (2025).
- DKSH Patient Solutions Patient support programs and healthcare solutions platform that supports disability-inclusive healthcare journeys and patient-centric engagement programs across Asia Pacific, including rare disease support initiatives and patient access programs.
- ConnectPlus by Euris AI-integrated customer relationship management platform that personalizes healthcare provider engagement based on real-time behavioral data, prescribing habits, channel preferences, and interaction history to deliver targeted engagement strategies for pharmaceutical clients.
- Lab Solutions by DKSH Online resource platform providing scientific expertise, testing services, and product information across food science, life science, material science, and pharmaceutical applications for Technology Business Unit customers.
- DKSH Premium Brands Luxury watches and accessories distribution entity in North America, part of DKSH's Consumer Goods portfolio serving premium and lifestyle brand owners.
Quantifiable outcome
- 5th consecutive year of Core EBIT margin expansion to 3.2%
- +7 more outcomes
Companies that use DKSH
Customer profileNamed customers20 records
Segments8 records
Ideal customer profiles4 records
DKSH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability7 records
Feature3 records
DKSH partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- BridgeBio PharmacoreStrategic distribution partnership for transthyretin stabilizer (ATTR-CM treatment) in Australia, Singapore, South Korea, and Taiwan. DKSH handles end-to-end distribution and commercialization pending regulatory approvals, combining BridgeBio's biotech innovation with DKSH Healthcare's regional market expertise.
- YeastupcoreExclusive distribution agreement for UpFiber Beta-Glucan ingredient (beer-waste-derived dietary fibre with up to 85% beta-glucan content) in DACH region (Germany, Austria, Switzerland). DKSH provides business development, marketing, sales, logistics, and distribution.
- LAUDAcorePartnership to launch LabPRO Cooling Thermostats for reliable laboratory temperature control, combining LAUDA's temperature control technology with DKSH's distribution network and application expertise.
- BUCHI Labortechnik AGcoreExpanded strategic partnership for laboratory technologies across nine Asia Pacific markets (Australia, Philippines, Vietnam, Cambodia, Indonesia, Korea, Laos, Malaysia, Myanmar, Singapore, Taiwan, Thailand). DKSH provides sales, marketing, application support, eCommerce, and after-sales services.
- Limagrain IngredientscoreExclusive distribution agreement for functional flours and plant-based ingredient solutions across six Southeast Asian markets: Malaysia, Philippines, Singapore, Thailand, Vietnam, and Indonesia. DKSH provides end-to-end services including marketing, sales, distribution, logistics, regulatory support, and technical application support.
- SanoficoreStrategic partnership to expand treatment access across Malaysia, Singapore, and Thailand, enabling Sanofi to reach more patients through DKSH's established distribution network and commercialization capabilities.
- medisanacoreStrategic partnership for home healthcare medical device distribution in Malaysia and Brunei. DKSH provides comprehensive market expansion services including sales, merchandising, distribution, and logistics across all retail and institutional pharmacy channels for products including blood pressure monitors, thermometers, inhalers, and blood glucose meters.
- HygienacoreExclusive partnerships for rapid diagnostic solutions across key ASEAN territories including Malaysia, Philippines, Laos, Myanmar, Cambodia, and Indonesia's hospital segment and Sumatra food and beverage sector. DKSH provides distribution, marketing, sales support, and demo unit investment.
- BayercoreStrategic business partnership for distribution and promotion of Bayer Pharmaceuticals across Singapore, Malaysia, Thailand, and Philippines. Covers cardiovascular products in all four markets plus women's health retail portfolio in Thailand, implementing end-to-end commercialization model.
- Kyowa KirincoreStrategic partnership for pharmaceutical products with broad regional coverage across Asia Pacific, driving strong sales performance through consistent communication and team alignment.
- LabVantageminorDistribution and implementation of LabVantage Laboratory Information Management System (LIMS) in Taiwan's pharmaceutical industry, marking first LIMS installation in Taiwan's pharma sector.
- Waters CorporationminorService partnership for Waters Xevo TQ Absolute Triple Quadrupole Mass Spectrometer. DKSH provides installation, troubleshooting, technical support, and application assistance through collaboration with Waters application team.
- HORIBAcoreLong-standing partnership for IVD solutions (hematology, clinical chemistry, coagulation) in Vietnam. DKSH provides regulatory navigation, sales and marketing, clinical application support, certified technical service network (3 centers), and CME programs. HORIBA has 1,000+ analyzers installed in Vietnam.
Scale indicators20 records
Recent moves7 records
Expansion highlights6 records
DKSH competitors and assessment
Company assessmentDirect peers
- Zuellig Pharma: Privately held Asia-focused pharma distribution and commercial services group covering 13+ markets. Most direct competitor to DKSH Healthcare with overlapping service lines (distribution, regulatory, market expansion) for multinational pharma principals.
- Brenntag: Global market leader in chemical and ingredients distribution (specialty chemicals, food ingredients, personal care ingredients). Direct comparable for DKSH Performance Materials business unit in ingredient and chemical distribution model.
- Azelis: Specialty chemicals and food ingredients distributor with strong presence in EMEA and Asia Pacific. Comparable to DKSH Performance Materials with similar value-added distribution, formulation support, and technical sales model.
- IMCD Group: Specialty chemicals and ingredients distributor operating globally with strong Asia Pacific presence. Comparable to DKSH Performance Materials in providing technical sales, formulation support, and market expansion for principals.
Broad incumbents
- Sinopharm Group: China's largest pharmaceutical distributor and state-owned enterprise with growing international footprint. Comparable in healthcare distribution scale and pharmaceutical supply chain role, though primarily China-domestic.
- McKesson: One of the largest global pharmaceutical wholesalers and healthcare services companies. Comparable in pharmaceutical distribution model but operates primarily in North America/Europe with broader services including retail pharmacy.
- Univar Solutions: Global chemical and ingredient distribution company serving similar industrial and consumer markets. Direct comparable for DKSH Performance Materials in specialty distribution across multiple verticals.
Emerging players
- Agilent Technologies: Scientific instruments and life science solutions provider operating through distributor networks including DKSH in Asia. Partial overlap with DKSH Technology BU's scientific solutions offerings but on the manufacturer side.
- Shimadzu Corporation: Japanese manufacturer of scientific instruments, analytical equipment, and medical devices distributed in part through DKSH Technology BU. Comparable in scientific/analytical instrument category but as a manufacturer-principal rather than distributor.
Regional players
- Wesco International: Global distribution and supply chain solutions provider for electronics, communications, and industrial markets. Comparable to DKSH Technology BU's semiconductor and electronics distribution but with North American focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
DKSH social profiles
Digital presenceDKSH compliance and trust
Trust signalCompliance4 records
DKSH financial estimates
Financial estimateRevenue estimate
Valuation estimate
DKSH leadership team
Management profileNumber of profiles
Profiles10 records
DKSH subsidiaries and ownership
Company hierarchySubsidiaries5 records
DKSH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DKSH M&A and investment
M&A and investmentM&A25 records
Investments6 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DKSH
What does DKSH do?
DKSH provides end-to-end Market Expansion Services across Asia Pacific, Europe, and North America, enabling multinational brand owners to enter and grow in regional markets without building their own infrastructure. Its services span sourcing, market insights, regulatory affairs, marketing, sales, distribution, logistics, warehousing, and after-sales support across four business units: Healthcare (pharma, consumer health, OTC, medical devices), Consumer Goods (FMCG, luxury, beauty, food service), Performance Materials (specialty chemicals and ingredients), and Technology (scientific instruments, precision machinery, semiconductor equipment).
Is DKSH a public or private company?
DKSH is a public company. It is classified as public and is currently operating.
When was DKSH founded?
DKSH was founded in 1869. It employs 5,001 to 10,000 people.
Where is DKSH based?
DKSH is headquartered in Zürich, Switzerland, in the Europe region.
How does DKSH make money?
Five revenue lines are on record. Distribution and Commercialization Services are the primary driver. The others are healthcare Distribution, consumer Goods Distribution, performance Materials Distribution and technology Distribution.
Who are DKSH's main competitors?
Direct peers on record are Zuellig Pharma, Brenntag, Azelis and IMCD Group. Broad incumbents are Sinopharm Group, McKesson and Univar Solutions. Emerging players are Agilent Technologies and Shimadzu Corporation. Wesco International is listed as a regional player.
Does DKSH have an API?
No public API is recorded for DKSH.
What industry is DKSH in?
DKSH's product category is Market Expansion Services. Its primary akta.pro industry code is HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor), with a secondary code of CRAOAHAG, Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience). Its NAICS code is 42421 and its SIC code is 5122.